Sister Cells Reveal Cancer’s Fate
A new method traces treatment resistant cells and predicts drugs that can make them more susceptible to cancer therapy. (Source: The Scientist)
Source: The Scientist - April 3, 2024 Category: Science Tags: News News & Opinion Source Type: news
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster drugs in its pipeline, this should bode well for growth at AZN.#fusion #azn (Source: Reuters: Health)
Source: Reuters: Health - March 26, 2024 Category: Consumer Health News Source Type: news
Syndax Announces FDA Priority Review of NDA for Revumenib for the Treatment of Relapsed/Refractory KMT2Ar Acute Leukemia
WALTHAM, Mass., March 26, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that the U.S. Food and Drug Administration (FDA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 26, 2024 Category: Drugs & Pharmacology Source Type: news
Regeneron's Blood Cancer Therapy Faces Setback as FDA Raises Trial Concerns Regeneron's Blood Cancer Therapy Faces Setback as FDA Raises Trial Concerns
Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its blood cancer therapy for two forms of lymphoma, raising concerns over the progress of...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 25, 2024 Category: Internal Medicine Tags: Hematology-Oncology Source Type: news
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line …
FLORHAM PARK, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. BYSI ("BeyondSpring" or the "Company"), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that the first patient has been dosed in a Phase 2…#beyondspringinc #iit #plinabulin #beyondspring #etoposideplatinumep #ep #agent3 #pd1 #mdanderson #plinabulindc (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2024 Category: Consumer Health News Source Type: news
US FDA grants full approval to AbbVie's ovarian cancer therapy
(Source: Reuters: Health)
Source: Reuters: Health - March 23, 2024 Category: Consumer Health News Source Type: news
Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics
A gastroenterologist and oncologist recently reviewed the appropriate assessment and treatment of patients with chemotherapy-associated diarrhea.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
Bayer AG and Thermo Fisher Scientific Inc. today announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help identify patients who may benefit from Bayer's growing portfolio of precision cancer therapies by offering decentralized genomic testing and rapid turnaround time. (Source: World Pharma News)
Source: World Pharma News - March 20, 2024 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026 Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026
Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech ' s manufacturing processes, an...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Next-generation CAR and TCR Cancer Therapies
From smart receptors to novel biologics, scientists plan to overcome the challenges
of treating solid tumors. (Source: The Scientist)
Source: The Scientist - March 15, 2024 Category: Science Tags: Features Magazine Issue Source Type: news
QT Imaging to deliver Breast Acoustic CT scanner to research centers
QT Imaging Holdings is delivering its Breast Acoustic CT scanner in collaboration with research centers in the U.S. and Canada.
The company is collaborating with the Department of Radiation Oncology and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, and the University of Illinois, Urbana-Champaign. This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach that can accurately identify early response of breast cancer patients to neoadjuvant ...
Source: AuntMinnie.com Headlines - March 14, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
New Immune-Focused Therapy, CAR T Cell Therapy, Shrinks Aggressive Brain Tumors
THURSDAY, March 14, 2024 -- Delivering dual-targeted, immune-focused CAR T cancer therapy via a patient ' s spinal fluid quickly shrank deadly brain tumors, researchers report.
CAR T therapy harnesses the power of the patient ' s immune system T-cells,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 14, 2024 Category: General Medicine Source Type: news
Drug Discount May Boost Adherence to Prostate Cancer Therapy Drug Discount May Boost Adherence to Prostate Cancer Therapy
The 340B drug discount program was not associated with oral specialty drug use in advanced prostate cancer but was linked to better adherence to medication in more vulnerable patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
'Silicon Forest' lab gets a piece of a $25M global children's cancer initiative grant
The Children ’s Cancer Therapy Development Institute is part of a five-member global consortium. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 6, 2024 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news
Cancer is no longer a death sentence, but treatments still have a long way to go
Recently, the US Food and Drug Administration approved a first-of-its-kind cancer therapy to treat aggresive forms of skin cancer. It has us thinking of the long history of cancer. One of the first recorded mentions of cancer appears in an ancient Egyptian text from around 3000 B.C. And although we now know much more about how cancer begins — as a series of mutations in someone's DNA — it's a disease people are still grappling with how to cure cancers today. This episode, cancer epidemiologist Mariana Stern talks about cancer history and treatment today — plus, why some people are more prone to certain cancers and wh...
Source: NPR Health and Science - March 4, 2024 Category: Consumer Health News Authors: Berly McCoy Source Type: news
